1. Home
  2. ONL vs CGEN Comparison

ONL vs CGEN Comparison

Compare ONL & CGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Orion Office REIT Inc.

ONL

Orion Office REIT Inc.

HOLD

Current Price

$2.06

Market Cap

111.5M

Sector

Real Estate

ML Signal

HOLD

Logo Compugen Ltd.

CGEN

Compugen Ltd.

HOLD

Current Price

$1.65

Market Cap

125.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ONL
CGEN
Founded
2021
1993
Country
United States
Israel
Employees
40
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
111.5M
125.3M
IPO Year
N/A
2000

Fundamental Metrics

Financial Performance
Metric
ONL
CGEN
Price
$2.06
$1.65
Analyst Decision
Hold
Analyst Count
1
0
Target Price
N/A
N/A
AVG Volume (30 Days)
284.6K
271.2K
Earning Date
11-06-2025
11-10-2025
Dividend Yield
3.96%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$149,775,000.00
$6,903,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$231.15
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.46
$1.13
52 Week High
$4.25
$2.66

Technical Indicators

Market Signals
Indicator
ONL
CGEN
Relative Strength Index (RSI) 30.80 53.50
Support Level $1.92 $1.47
Resistance Level $2.31 $1.61
Average True Range (ATR) 0.10 0.09
MACD -0.02 0.01
Stochastic Oscillator 26.53 72.03

Price Performance

Historical Comparison
ONL
CGEN

About ONL Orion Office REIT Inc.

Orion Properties Inc is a internally-managed REIT engaged in the ownership, acquisition, and management of a diversified portfolio of mission-critical and headquarters office buildings located in high quality suburban markets across the U.S. and leased on a single-tenant net lease basis to creditworthy clients. The portfolio of the company includes traditional office buildings, governmental offices, medical offices, laboratories, and others. The Company operates in one business segment: direct ownership and operation of commercial real estate.

About CGEN Compugen Ltd.

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902 and bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.

Share on Social Networks: